Mon, Aug 13, 2018
Go to original document
OPKO HEALTH, INC. (OPK)
Healthcare
Diagnostics & Research
1.33 USD
-1.23 (-48.05%) Past 5Y
1W
1M
6M
1Y
5Y
MAX
200003 AM06 AM09 AM12 PM03 PM06 PM09 PMJan 021970.001.002.003.004.00520052010201520202021202220232024202500.20.40.60.8123451015206
Insights
Coming soon
Non Derivative Transactions
2018-08-13
Common Stock
Purchase
P
Type
Acquired 600 shares @ $5.28 per share
4,293,470 shares
See Footnote
Indirect
2018-08-13
Common Stock
Purchase
P
Type
Acquired 4,400 shares @ $5.28 per share
4,297,870 shares
See Footnote
Indirect
2018-08-13
Common Stock
Purchase
P
Type
Acquired 1,000 shares @ $5.31 per share
4,298,870 shares
See Footnote
Indirect
2018-08-13
Common Stock
Purchase
P
Type
Acquired 1,000 shares @ $5.32 per share
4,299,870 shares
See Footnote
Indirect
2018-08-13
Common Stock
Purchase
P
Type
Acquired 2,408 shares @ $5.33 per share
4,302,278 shares
See Footnote
Indirect
2018-08-13
Common Stock
Purchase
P
Type
Acquired 2,592 shares @ $5.34 per share
4,304,870 shares
See Footnote
Indirect
2018-08-13
Common Stock
Purchase
P
Type
Acquired 200 shares @ $5.41 per share
4,305,070 shares
See Footnote
Indirect
2018-08-13
Common Stock
Purchase
P
Type
Acquired 2,800 shares @ $5.41 per share
4,307,870 shares
See Footnote
Indirect
Common Stock
Other
Type
Disposed 0 shares @ $0.00 per share
3,068,951 shares
Direct
Common Stock
Other
Type
Disposed 0 shares @ $0.00 per share
164,234,448 shares
See Footnote
Indirect
Common Stock
Other
Type
Disposed 0 shares @ $0.00 per share
20,091,062 shares
See Footnote
Indirect
Footnotes
1. These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of five limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2. The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
3. These securities are owned directly by The Frost Group, LLC. Frost Gamma Investments Trust is a principal member of The Frost Group, LLC. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.